Anemia and Red Blood Cell Transfusion: Advances in Critical Care

Critical Care Clinics

Volumn 33, Issue 2, 2017, Pages 345-364

  Napolitano, Lena M ^a  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

Anemia; Blood transfusion; Critical care; Critically ill; Hemoglobin; Red blood cell transfusion; Transfusion

Indexed keywords

ANTIANEMIC AGENT; ERYTHROFERRONE; ERYTHROPOIETIN; FERRIC CARBOXYMALTOSE; HEMOGLOBIN; HEPCIDIN; IRON; PEPTIDE HORMONE; UNCLASSIFIED DRUG;

ACUTE CORONARY SYNDROME; ACUTE RESPIRATORY FAILURE; ANEMIA; ARTIFICIAL VENTILATION; BLOOD SAMPLING; CARDIOVASCULAR DISEASE; CRITICALLY ILL PATIENT; DISEASE SEVERITY; ERYTHROCYTE TRANSFUSION; ERYTHROPOIESIS; HEART SURGERY; HEMOGLOBIN BLOOD LEVEL; HORMONE BLOOD LEVEL; HUMAN; INFLAMMATION; INTENSIVE CARE; IRON ABSORPTION; IRON STORAGE; IRON THERAPY; MEDICAL DECISION MAKING; NUTRITIONAL SUPPORT; PATHOPHYSIOLOGY; PATIENT PREFERENCE; PHLEBOTOMY; PROTEIN BLOOD LEVEL; REVIEW; SEPSIS; SEPTIC SHOCK; VITAMIN SUPPLEMENTATION; PROCEDURES;

ANEMIA; CRITICAL CARE; ERYTHROCYTE TRANSFUSION; HUMANS;

EID: 85014644682     PISSN: 07490704     EISSN: 15578232     Source Type: Journal    
DOI: 10.1016/j.ccc.2016.12.011     Document Type: Review

References (106)

1. 1 Vincent, J.L., Baron, J.F., Reinhart, K., et al., ABC (Anemia and Blood Transfusion in Critical Care) Investigators. Anemia and blood transfusion in critically ill patients. JAMA 288 (2002), 1499–1507.
2. 2 Vincent, J.L., Sakr, Y., Sprung, C., et al. Are blood transfusion associated with greater mortality rates? Results of the sepsis occurrence in acutely ill patients (SOAP) study. Anesthesiology 108 (2008), 31–39.
3. 3 Corwin, H.L., Gettinger, A., Pearl, R.G., et al. The CRIT Study: anemia and blood transfusion in the critically ill—current clinical practice in the United States. Crit Care Med 32 (2004), 39–52.
4. 4 Shapiro, M.J., Gettinger, A., Corwin, H., et al. Anemia and blood transfusion in trauma patients admitted to the intensive care unit. J Trauma 55 (2003), 269–274.
5. 5 Hebert, P.C., Wells, G., Blajchman, M.A., et al. A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care investigators, Canadian Critical Care Trials Group. N Engl J Med 340 (1999), 409–417.
6. 6 Rao, M.P., Boralessa, H., Morgan, C., et al. Blood component use in critically ill patients. Anaesthesia 57 (2002), 530–534.
7. 7 Walsh, T.S., Garrioch, M., Maciver, C., et al., Audit of Transfusion in Intensive Care in Scotland Study Group. Red cell requirements for intensive care units adhering to evidence-based transfusion guidelines. Transfusion 44 (2004), 1405–1411.
8. 8 Walsh, T.S., McClelland, D.B., Lee, R.J., et al. Prevalence of ischemic heart disease at admission to intensive care and its influence on red cell transfusion thresholds: multicenter Scottish Study. Br J Anaesth 94 (2005), 445–452.
9. 9 Shehata, N., Forster, A., Lawrence, N., et al. Changing trends in blood transfusion: an analysis of 244,013 hospitalizations. Transfusion 54:10 Pt 2 (2014), 2631–2639.
10. 10 Palmieri, T.L., Caruso, D.M., Foster, K.N., et al. Effect of blood transfusion on outcome after major burn injury: a multicenter study. Crit Care Med 34 (2006), 1602–1607.
11. 11 Seitz, K.P., Sevransky, J.E., Martin, G.S., et al. Evaluation of RBC transfusion practice in adult ICUs and the effect of restrictive transfusion protocols on routine care. Crit Care Med, 2016 [Epub ahead of print].
12. 12 Hayden, S.J., Albert, T.J., Watkins, T.R., et al. Anemia in critical illness: insights into etiology, consequences, and management. Am J Respir Crit Care Med 185:10 (2012), 1049–1057.
13. 13 Sihler, K.C., Raghavendran, K., Westerman, M., et al. Hepcidin in trauma: linking injury, inflammation, and anemia. J Trauma 69 (2010), 831–837.
14. 14 Girelli, D., Nemeth, E., Swinkels, D.W., Hepcidin in the diagnosis of iron disorders. Blood 127:23 (2016), 2809–2813.
15. 15 Kautz, L., Jung, G., Valore, E.V., et al. Identification of erythroferrone as an erythroid regulator of iron metabolism. Nat Genet 46:7 (2014), 678–684.
16. 16 Vincent, J.L., Which carries the biggest risk: anaemia or blood transfusion?. Transfus Clin Biol 22:3 (2015), 148–150.
17. 17 Mirski, M.A., Frank, S.M., Kor, D.J., et al. Restrictive and liberal red cell transfusion strategies in adult patients: reconciling clinical data with best practice. Crit Care, 19, 2015, 202.
18. 18 Napolitano, L.M., Corwin, H.L., Efficacy of red blood cell transfusion in the critically ill. [review] Crit Care Clin 20:2 (2004), 255–268.
19. 19 Josephson, C.D., Glynn, S.A., Kleinman, S.H., et al., State-of-the Science Symposium Transfusion Medicine Committee. A multidisciplinary “think tank”: the top 10 clinical trial opportunities in transfusion medicine from the National Heart, Lung, and Blood Institute-sponsored 2009 state-of-the-science symposium. Transfusion 51:4 (2011), 828–841.
20. 20 Blajchman, M.A., Glynn, S.A., Josephson, C.D., et al., State-of-the Science Symposium Transfusion Medicine Committee. Clinical trial opportunities in transfusion medicine: proceedings of a National Heart, Lung, and Blood Institute state-of-the-science symposium. Transfus Med Rev 24:4 (2010), 259–285.
21. 21 Fowler, R.A., Berenson, M., Blood conservation in the intensive care unit. Crit Care Med 31 (2003), 653–657.
22. 22 Chant, C., Wilson, G., Friedrich, J.O., Anemia, transfusion, and phlebotomy practices in critically ill patients with prolonged ICU length of stay: a cohort study. Crit Care, 10, 2006, R140.
23. 23 Shaffer, C., Diagnostic blood loss in mechanically ventilated patients. Heart Lung 36 (2007), 217–222.
24. 24 Smoller, B.R., Kruskall, M.S., Horowitz, G.L., Reducing adult phlebotomy blood loss with the use of pediatric-sized blood collection tubes. Am J Clin Pathol 91 (1989), 701–703.
25. 25 Dolman, H.S., Evans, K., Zimmerman, L.H., et al. Impact of minimizing diagnostic blood loss in the critically ill. Surgery 158:4 (2015), 1083–1087.
26. 26 Page, C., Retter, A., Wyncoll, D., Blood conservation devices in critical care: a narrative review. Ann Intensive Care, 3, 2013, 14.
27. 27 Mukhopadhyay, A., Yip, H.S., Prabhuswamy, D., et al. The use of a blood conservation device to reduce red blood cell transfusion requirements: a before and after study. Crit Care, 14(1), 2010, R7.
28. 28 MacIsaac, C.M., Presneill, J.J., Boyce, C.A., et al. The influence of a blood conserving device on anaemia in intensive care patients. Anaesth Intensive Care 31:6 (2003), 653–657.
29. 29 Peruzzi, W.T., Parker, M.A., Lichtenthal, P.R., et al. A clinical evaluation of a blood conservation device in medical intensive care unit patients. Crit Care Med 21 (1993), 501–506.
30. 30 Carless, P.A., Henry, D.A., Moxey, A.J., et al. Cell salvage for minimising perioperative allogeneic blood transfusion. Cochrane Database Syst Rev(4), 2010 CD001888.
31. 31 KDIGO anemia work group, KDIGO clinical practice guideline for anemia in chronic kidney disease. Kidney Int Suppl 2:4 (2012), 279–335.
32. 32 Corwin, H.L., Gettinger, A., Rodriguez, R.M., et al. Efficacy of recombinant human erythropoietin in the critically ill patient: a randomized, double-blind, placebo-controlled trial. Crit Care Med 27 (1999), 2346–2350.
33. 33 Corwin, H.L., Gettinger, A., Pearl, R.G., et al. Efficacy of recombinant human erythropoietin in critically ill patients: a randomized controlled trial. JAMA 288 (2002), 2827–2835.
34. 34 Corwin, H.L., Gettinger, A., Fabian, T.C., et al. Efficacy and safety of epoetin alfa in critically ill patients. N Engl J Med 357 (2007), 965–976.
35. 35 Silver, M., Corwin, M.J., Bazan, A., et al. Efficacy of recombinant human erythropoietin in critically ill patients admitted to a long-term acute care facility: a randomized, double-blind, placebo-controlled trial. Crit Care Med 34 (2006), 2310–2316.
36. 36 Zarychanski, R., Turgeon, A.F., McIntyre, L., et al. Erythropoietin-receptor agonists in critically ill patients: a meta-analysis of randomized controlled trials. CMAJ 177 (2007), 725–734.
37. 37 Napolitano, L.M., Fabian, T.C., Kelly, K.M., et al. Improved survival of critically ill trauma patients treated with recombinant human erythropoietin. J Trauma 65:2 (2008), 285–297 [discussion: 297–9].
38. 38 French, C.J., Glassford, N.J., Gantner, D., et al. Erythropoiesis-stimulating agents in critically ill trauma patients: a systematic review and meta-analysis. Ann Surg 265:1 (2017), 54–62.
39. 39 Corwin, H.L., Napolitano, L.M., Erythropoietin for critically ill trauma patients: a missed opportunity?. J Trauma Acute Care Surg 77:5 (2014), 774–779.
40. 40 Shah, A., Roy, N.B., McKechnie, S., et al. Iron supplementation to treat anaemia in adult critical care patients: a systematic review and meta-analysis. Crit Care, 20(1), 2016, 306.
41. 41 Pieracci, F.M., Henderson, P., Rodney, J.R., et al. Randomized, double-blind, placebo-controlled trial of effects of enteral iron supplementation on anemia and risk of infection during surgical critical illness. Surg Infect (Larchmt) 10:1 (2009), 9–19.
42. 42 Pieracci, F.M., Stovall, R.T., Jaouen, B., et al. A multicenter, randomized clinical trial of IV iron supplementation for anemia of traumatic critical illness. Crit Care Med 42:9 (2014), 2048–2057.
43. 43 IRONMAN Investigators, Litton, E., Baker, S., et al., Australian and New Zealand Intensive Care Society Clinical Trials Group. Intravenous iron or placebo for anaemia in intensive care: the IRONMAN multicentre randomized blinded trial: a randomized trial of IV iron in critical illness. Intensive Care Med 42:11 (2016), 1715–1722.
44. 44 Onken, J.E., Bregman, D.B., Harrington, R.A., et al. Ferric carboxymaltose in patients with iron-deficiency anemia and impaired renal function: the REPAIR-IDA trial. Nephrol Dial Transplant 29:4 (2014), 833–842.
45. 45 Rodriguez, R.M., Corwin, H.L., Gettinger, A., et al. Nutritional deficiencies and blunted erythropoietin response as causes of the anemia of critical illness. J Crit Care 16 (2001), 36–41.
46. 46 Sasaki, Y., Noguchi-Sasaki, M., Yasuno, H., et al. Erythropoietin stimulation decreases hepcidin expression through hematopoietic activity on bone marrow cells in mice. Int J Hematol 96:6 (2012), 692–700.
47. 47 Corwin, H.L., Napolitano, L.M., Anemia in the critically ill: do we need to live with it?. Crit Care Med 42:9 (2014), 2140–2141.
48. 48 Ruchala, P., Nemeth, E., The pathophysiology and pharmacology of hepcidin. Trends Pharmacol Sci 35:3 (2014), 155–161.
49. 49 Available at: http://www.sabm.org/. Accessed October 2, 2015.
50. 50 Murphy, M.F., Goodnough, L.T., The scientific basis for patient blood management. Transfus Clin Biol 22:3 (2015), 90–96.
51. 51 Oliver, J.C., Griffin, R.L., Hannon, T., et al. The success of our patient blood management program depended on an institution-wide change in transfusion practices. Transfusion 54:10 Pt 2 (2014), 2617–2624.
52. 52 Leahy, M.F., Roberts, H., Mukhtar, S.A., et al., Western Australian Patient Blood Management Program. A pragmatic approach to embedding patient blood management in a tertiary hospital. Transfusion 54:4 (2014), 1133–1145.
53. 53 Mehra, T., Seifert, B., Bravo-Reiter, S., et al. Implementation of a patient blood management monitoring and feedback program significantly reduces transfusions and costs. Transfusion 55:12 (2015), 2807–2815.
54. 54 Gross, I., Seifert, B., Hofmann, A., et al. Patient blood management in cardiac surgery results in fewer transfusions and better outcome. Transfusion 55:5 (2015), 1075–1081.
55. 55 Theusinger, O.M., Kind, S.L., Seifert, B., et al. Patient blood management in orthopaedic surgery: a four-year follow-up of transfusion requirements and blood loss from 2008 to 2011 at the Balgrist University Hospital in Zurich, Switzerland. Blood Transfus 12:2 (2014), 195–203.
56. 56 Goodnough, L.T., Maggio, P., Hadhazy, E., et al. Restrictive blood transfusion practices are associated with improved patient outcomes. Transfusion 54:10 Pt 2 (2014), 2753–2759.
57. 57 Roubinian, N.H., Escobar, G.J., Liu, V., et al., NHLBI Recipient Epidemiology and Donor Evaluation Study (REDS-III). Trends in red blood cell transfusion and 30-day mortality among hospitalized patients. Transfusion 54:10 Pt 2 (2014), 2678–2686.
58. 58 Available at: https://www.blood.gov.au/system/files/documents/pbm-module-4.pdf. Accessed October 2, 2015.
59. 59 Available at: http://www.jointcommission.org/electronic_clinical_quality_measures_for_patient_blood_management/. Accessed October 2, 2015.
60. 60 Rohde, J.M., Dimcheff, D.E., Blumberg, N., et al. Health care-associated infection after red blood cell transfusion: a systematic review and meta-analysis. JAMA 311:13 (2014), 1317–1326.
61. 61 Napolitano, L.M., Kurek, S., Luchette, F.A., et al. Clinical practice guideline: red blood cell transfusion in adult trauma and critical care. Crit Care Med 37 (2009), 3124–3157.
62. 62 Carson, J.L., Guyatt, G., Heddle, N.M., et al. Clinical practice guidelines from the AABB: red blood cell transfusion thresholds and storage. JAMA 316:19 (2016), 2025–2035.
63. 63 Salpeter, S.R., Buckley, J.S., Chatterjee, S., Impact of more restrictive blood transfusion strategies on clinical outcomes: a meta-analysis and systematic review. Am J Med 127 (2014), 124–131.
64. 64 Carson, J.L., Carless, P.A., Hebert, P.C., Transfusion thresholds and other strategies for guiding allogeneic red blood cell transfusion. Cochrane Database Syst Rev(4), 2012 CD002042.
65. 65 Roubinian, N.H., Carson, J.L., Restrictive red blood cell transfusion strategies appear safe in most clinical settings. Evid Based Med, 20(5), 2015, 170.
66. 66 Holst, L.B., Petersen, M.W., Haase, N., et al. Restrictive versus liberal transfusion strategy for red blood cell transfusion: systematic review of randomised trials with meta-analysis and trial sequential analysis. BMJ, 350, 2015, h1354.
67. 67 Spahn, D.R., Spahn, G.H., Stein, P., Evidence base for restrictive transfusion triggers in high-risk patients. Transfus Med Hemother 42:2 (2015), 110–114.
68. 68 Chang, R., Holcomb, J.B., Optimal fluid therapy for traumatic hemorrhagic shock. Crit Care Clin 33:1 (2017), 15–36.
69. 69 McIntyre, L., Hebert, P.C., Wells, G., et al., Canadian Critical Care Trials Group. Is a restrictive transfusion strategy safe for resuscitated and critically ill trauma patients?. J Trauma 57:3 (2004), 563–568 [discussion: 568].
70. 70 West, M.A., Shapiro, M.B., Nathens, A.B., et al., Inflammation and the Host Response to Injury Collaborative Research Program. Inflammation and the host response to injury, a large-scale collaborative project: patient-oriented research core-standard operating procedures for clinical care. IV. Guidelines for transfusion in the trauma patient. J Trauma 61:2 (2006), 436–439.
71. 71 Rivers, E., Nguyen, B., Havstad, S., et al., Early Goal-Directed Therapy Collaborative Group. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 345:19 (2001), 1368–1377.
72. 72 Fuller, B.M., Gajera, M., Schorr, C., et al. Transfusion of packed red blood cells is not associated with improved central venous oxygen saturation or organ function in patients with septic shock. J Emerg Med 43:4 (2012), 593–598.
73. 73 Marik, P.E., Sibbald, W.J., Effect of stored-blood transfusion on oxygen delivery in patients with sepsis. JAMA 269 (1993), 3024–3030.
74. 74 Dietrich, K.A., Conrad, S.A., Hebert, C.A., et al. Cardiovascular and metabolic response to red blood cell transfusion in critically ill volume-resuscitated nonsurgical patients. Crit Care Med 18 (1990), 940–944.
75. 75 Conrad, S.A., Dietrich, K.A., Hebert, C.A., et al. Effect of red cell transfusion on oxygen consumption following fluid resuscitation in septic shock. Circ Shock 31 (1990), 419–429.
76. 76 Mazza, B.F., Machado, F.R., Mazza, D.D., et al. Evaluation of blood transfusion effects on mixed venous oxygen saturation and lactate levels in patients with SIRS/sepsis. Clinics (Sao Paulo) 60 (2005), 311–316.
77. 77 Holst, L.B., Haase, N., Wetterslev, J., for the TRISS Trial Group and the Scandinavian Critical Care Trials Group. Lower versus higher hemoglobin threshold for transfusion in septic shock. N Engl J Med 371 (2014), 1381–1391.
78. 78 Rygård, S.L., Holst, L.B., Wetterslev, J., et al., TRISS Trial Group; Scandinavian Critical Care Trials Group. Higher vs. lower haemoglobin threshold for transfusion in septic shock: subgroup analyses of the TRISS trial. Acta Anaesthesiol Scand 61:2 (2017), 166–175.
79. 79 Rygård, S.L., Holst, L.B., Wetterslev, J., et al., TRISS Trial Group; Scandinavian Critical Care Trials Group. Long-term outcomes in patients with septic shock transfused at a lower versus a higher haemoglobin threshold: the TRISS randomised, multicentre clinical trial. Intensive Care Med 42:11 (2016), 1685–1694.
80. 80 Angus, D.C., Yealy, D.M., Kellum, J.A., ProCESS Investigators. Protocol-based care for early septic shock. N Engl J Med, 371(4), 2014, 386.
81. 81 ARISE Investigators; ANZICS Clinical Trials Group, Peake, S.L., Delaney, A., Bailey, M., et al. Goal-directed resuscitation for patients with early septic shock. N Engl J Med 371:16 (2014), 1496–1506.
82. 82 Mouncey, P.R., Osborn, T.M., Power, G.S., et al., ProMISe Trial Investigators. Trial of early, goal-directed resuscitation for septic shock. N Engl J Med 372:14 (2015), 1301–1311.
83. 83 Levy, M.M., Abraham, E., Zilberberg, M., et al. A descriptive evaluation of transfusion practices in patients receiving mechanical ventilation. Chest 127 (2005), 928–935.
84. 84 Hébert, P.C., Blajchman, M.A., Cook, D.J., et al. Transfusion requirements in critical care investigators for the Canadian critical care trials group: do blood transfusions improve outcomes related to mechanical ventilation?. Chest 119 (2001), 1850–1857.
85. 85 Walsh, T.S., Boyd, J.A., Watson, D., et al., RELIEVE Investigators. Restrictive versus liberal transfusion strategies for older mechanically ventilated critically ill patients: a randomized pilot trial. Crit Care Med 41:10 (2013), 2354–2363.
86. 86 Salisbury, A.C., Amin, A.P., Reid, K.J., et al. Hospital-acquired anemia and in-hospital mortality in patients with acute myocardial infarction. Am Heart J 162:2 (2011), 300–309.
87. 87 Salisbury, A.C., Kosiborod, M., Amin, A.P., et al. Recovery from hospital-acquired anemia after acute myocardial infarction and effect on outcomes. Am J Cardiol 108:7 (2011), 949–954.
88. 88 Salisbury, A.C., Reid, K.J., Amin, A.P., et al. Variation in the incidence of hospital-acquired anemia during hospitalization with acute myocardial infarction (data from 57 US hospitals). Am J Cardiol 113:7 (2014), 1130–1136.
89. 89 Hanna, E.B., Alexander, K.P., Chen, A.Y., et al. Characteristics and in-hospital outcomes of patients with non-ST-segment elevation myocardial infarction undergoing an invasive strategy according to hemoglobin levels. Am J Cardiol 111:8 (2013), 1099–1103.
90. 90 Wu, W.C., Rathore, S.S., Wang, Y., et al. Blood transfusion in elderly patients with acute myocardial infarction. [comment] N Engl J Med 345:17 (2001), 1230–1236.
91. 91 Hebert, P.C., Fergusson, D.A., Do transfusions get to the heart of the matter?. JAMA 292 (2004), 1610–1612.
92. 92 KP1, Alexander, Chen, A.Y., Wang, T.Y., et al. Transfusion practice and outcomes in non-ST-segment elevation acute coronary syndromes. Am Heart J 155:6 (2008), 1047–1053.
93. 93 Salisbury, A.C., Reid, K.J., Marso, S.P., et al. Blood transfusion during acute myocardial infarction: association with mortality and variability across hospitals. J Am Coll Cardiol 64:8 (2014), 811–819.
94. 94 Rao, S.V., Jollis, J.G., Harrington, R.A., et al. Relationship of blood transfusion and clinical outcomes in patients with acute coronary syndromes [see comment]. JAMA 292:13 (2004), 1555–1562.
95. 95 Shishehbor, M.H., Madhwal, S., Rajagopal, V., et al. Impact of blood transfusion on short- and long-term mortality in patients with ST-segment elevation myocardial infarction. JACC Cardiovasc Interv 2:1 (2009), 46–53.
96. 96 Chatterjee, S., Wetterslev, J., Sharma, A., et al. Association of blood transfusion with increased mortality in myocardial infarction: a meta-analysis and diversity-adjusted study sequential analysis. JAMA Intern Med 173 (2013), 132–139.
97. 97 Carson, J.L., Hebert, P.C., Here we go again—blood transfusion kills patients?. JAMA Intern Med 173 (2013), 139–140.
98. 98 Gerber, D.R., Transfusion of packed red blood cells in patients with ischemic heart disease. Crit Care Med 36:4 (2008), 1068–1074.
99. 99 Cooper, H.A., Rao, S.V., Greenberg, M.D., et al. Conservative versus liberal red cell transfusion in acute myocardial infarction (the CRIT Randomized Pilot Study). Am J Cardiol 108:8 (2011), 1108–1111.
100. 100 Carson, J.L., Brooks, M.M., Abbott, J.D., et al. Liberal versus restrictive transfusion thresholds for patients with symptomatic coronary artery disease. Am Heart J 165:6 (2013), 964–971.
101. 101 Hébert, P.C., Yetisir, E., Martin, C., et al., Transfusion Requirements in Critical Care Investigators for the Canadian Critical Care Trials Group. Is a low transfusion threshold safe in critically ill patients with cardiovascular diseases?. Crit Care Med 29:2 (2001), 227–234.
102. 102 Carson, J.L., Terrin, M.L., Noveck, H., et al., FOCUS Investigators. Liberal or restrictive transfusion in high-risk patients after hip surgery. N Engl J Med 365:26 (2011), 2453–2462.
103. 103 Carson, J.L., Sieber, F., Cook, D.R., et al. Liberal versus restrictive blood transfusion strategy: 3-year survival and cause of death results from the FOCUS randomised controlled trial. Lancet 385 (2015), 1183–1189.
104. 104 Hajjar, L.A., Vincent, J.L., Galas, F.R., et al. Transfusion requirements after cardiac surgery: the TRACS randomized controlled trial. JAMA 304 (2010), 1559–1567.
105. 105 Nakamura, R.E., Vincent, J.L., Fukushima, J.T., et al. A liberal strategy of red blood cell transfusion reduces cardiogenic shock in elderly patients undergoing cardiac surgery. J Thorac Cardiovasc Surg 150:5 (2015), 1314–1320.
106. 106 Murphy, G.J., Pike, K., Rogers, C.A., et al., TITRe2 Investigators. Liberal or restrictive transfusion after cardiac surgery. N Engl J Med, 372, 2015, 9971008.